Roxadustat in treating anemia in dialysis patients (ROAD): protocol and rationale of a multicenter prospective observational cohort study

Abstract Background Roxadustat has been shown effective in treating patients with anemia due to chronic kidney disease. However, its long-term effect on clinical outcomes and socioeconomic burden and safety remains unclear. Methods/Design This is a multicenter, prospective, longitudinal observationa...

Cijeli opis

Bibliografski detalji

Glavni autori:	Yaling Zhang, Song Ren, Hen Xue, Amanda Y Wang, Yang Zou, Yanrong Cai, Jingdong He, Xiaoling Yuan, Feifei Jiang, Jinxi Wei, Dongmei Yang, Dong He, Shide Hu, Min Lei, Fei Deng, Jin Chen, Xia Wang, Qiang He, Guisen Li, Daqing Hong
Format:	Artigo
Jezik:	Inglês
Izdano:	BMC 2021-01-01
Serija:	BMC Nephrology
Teme:	Roxadustat renal anemia hemodialysis
Online pristup:	https://doi.org/10.1186/s12882-021-02229-w
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!